QA: Orgenesis Inc in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001460602_2018_Orgenesis_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001460602, Orgenesis Inc

  xvar xval
0 AssetsCurrent 7,295,000
1 IntangibleAssetsNetIncludingGoodwill 25,735,000
2 PropertyPlantAndEquipmentNet 5,104,000
3 remainder_Assets 1,738,000
4 LiabilitiesCurrent 16,914,000
5 LiabilitiesNoncurrent 5,229,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 6,807,000
8 SellingGeneralAndAdministrativeExpense 9,189,000
9 ResearchAndDevelopmentExpense 2,478,000
10 remainder_Expenses 321,000
11 remainder_Revenues 10,089,000
12 remainder_NetIncome -3,661,000
13 remainder_ComprehensiveNetIncome 2,630,000
  yvar yval
0 Assets 39,872,000
1 Liabilities 22,143,000
2 Expenses 18,795,000
3 Revenues 10,089,000
4 StockholdersEquity 17,729,000
5 NetIncome -12,367,000
6 ComprehensiveNetIncome -11,052,000
7 BaseVar 48,595,000
8 EconomicCapitalRatiobeforeLimitedLiability 0.890
9 EconomicCapitalRatio 2.21

Edgar->Model Mapping

Feature Distribution

Change over Time